Amcor plc and Berry Global Group, Inc. announced on January 23, 2025, an important milestone towards the completion of their all-stock transaction with the filing of the definitive joint proxy statement with the U.S. SEC. Shareholder meetings for both Amcor and Berry are scheduled to take place on Tuesday, February 25, 2025.
The transaction is expected to create a global leader in consumer and healthcare packaging solutions, uniquely positioned to accelerate growth across a broader portfolio. Substantial value is anticipated through $650 million in identified cost, growth, and financial synergies.
The combination is projected to deliver over 35% adjusted cash earnings per share accretion and enhance long-term shareholder valuation creation from 10-15% to 13-18% per annum. The transaction is unanimously recommended by the Boards of Directors of both companies, with expected completion in mid-calendar year 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.